Brief: DSM FY Adjusted EBITDA From Continuing Operations Up At EUR 1.81 Bln
15/02/2022 06:19
Feb 15 (Reuters) - Koninklijke DSM NV DSMN.AS :
* DSM REPORTS 2021 RESULTS
* FY NET PROFIT FROM CONTINUING OPERATIONS 1.68 BILLION EUR
* WE HAVE A POSITIVE OUTLOOK FOR 2022 IN LINE WITH OUR
MID-TERM
STRATEGIC TARGETS FOR OUR HEALTH, NUTRITION & BIOSCIENCE
ACTIVITIES
* IN 2022 DSM EXPECTS ITS HEALTH, NUTRITION & BIOSCIENCE
ACTIVITIES TO DELIVER A HIGH-SINGLE DIGIT ADJUSTED EBITDA
INCREASE
* FY NUTRITION: SALES +10%, ORGANIC SALES +8%, ADJUSTED
EBITDA +8%
FROM CONTINUING OPERATIONS
* IN 2022 FOR GROUP, IT EXPECTS A MID-SINGLE DIGIT ADJUSTED
EBITDA
INCREASE, WITH A HIGH-SINGLE DIGIT ADJUSTED NET OPERATING FREE
CASH FLOW INCREASE
* THIS OUTLOOK IS BASED ON DSM'S EXPECTATION OF A STABLE
ADJUSTED
EBITDA IN MATERIALS FOLLOWING STRONG PERFORMANCE IN 2021
* FY MATERIALS: SALES +27%, ORGANIC SALES +28%, ADJUSTED
EBITDA
+60% FROM CONTINUING OPERATIONS
* PROPOSED DIVIDEND INCREASE BY EUR 0.10 TO EUR 2.50 PER
ORDINARY
SHARE
* FY ADJUSTED NET PROFIT FROM CONTINUING OPERATION UP 21% TO
€858M
* FY NET PROFIT OF EUR 1,680M, INCLUDING PROFITS FROM SALE
OF AOC
AND RESINS & FUNCTIONAL MATERIALS
* FY ADJUSTED NET OPERATING FREE CASH FLOW FROM OPERATING
OPERATIONS OF €949M, UP 9%
* FY ADJUSTED EBITDA FROM CONTINUING OPERATIONS EUR 1.81
BILLION
VERSUS EUR 1.53 BILLION YEAR AGO
* MAINTAINS AMBITIOUS MID-TERM PROFIT TARGETS
* FY NET PROFIT OF €1,680M, INCLUDING PROFITS FROM THE SALE
OF AOC
AND RESINS & FUNCTIONAL MATERIALS
* WE STARTED TO COUNTER INFLATIONARY PRESSURES IN SECOND
HALF OF
YEAR WITH APPROPRIATE PRICING ACTIONS TO OFFSET COST INCREASES,
OF WHICH FIRST POSITIVE EFFECTS CAN BE SEEN IN Q4, WITH
REMAINDER BEING EFFECTIVE AS OF 2022
* ANIMAL NUTRITION REALIZED 7% HIGHER PRICES IN THE QUARTER
AND
FURTHER PRICE INCREASES WILL BE EFFECTIVE AS OF 2022
Source text for Eikon: ID:nPreVrL6Ja
Further company coverage: DSMN.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))